Cargando…
Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation
BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, thi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299653/ https://www.ncbi.nlm.nih.gov/pubmed/28178976 http://dx.doi.org/10.1186/s12933-017-0505-y |
_version_ | 1782506066687295488 |
---|---|
author | Furukawa, Kazuo Fuse, Ichiro Iwakura, Yuriko Sotoyama, Hidekazu Hanyu, Osamu Nawa, Hiroyuki Sone, Hirohito Takei, Nobuyuki |
author_facet | Furukawa, Kazuo Fuse, Ichiro Iwakura, Yuriko Sotoyama, Hidekazu Hanyu, Osamu Nawa, Hiroyuki Sone, Hirohito Takei, Nobuyuki |
author_sort | Furukawa, Kazuo |
collection | PubMed |
description | BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, this may represent dysregulation of BDNF release from platelets. Here we focused on advanced glycation end products (AGEs), which are elevated in patients with DM and have adverse effects on cardiovascular functions. The aim of this study is to elucidate the role of AGEs in the regulation of BDNF release from human platelets. METHODS: Platelets collected from peripheral blood of healthy volunteers were incubated with various concentrations of AGE (glycated-BSA) at 37 °C for 5 min with or without BAPTA-AM, a cell permeable Ca(2+) chelator, or PP2, a potent inhibitor of Src family kinases (SFKs). Released and cellular BDNF were measured by ELISA and calculated. Phosphorylation of Src and Syk, a downstream kinase of SFKs, in stimulated platelets was examined by Western blotting and immunoprecipitation. RESULTS: AGE induced BDNF release from human platelets in a dose-dependent manner, which was dependent on intracellular Ca(2+) and SFKs. We found that AGE induced phosphorylation of Src and Syk. CONCLUSIONS: AGE induces BDNF release from human platelets through the activation of the Src-Syk-(possibly phospholipase C)-Ca(2+) pathway. Considering the toxic action of AGEs and the protective roles of BDNF, it can be hypothesized that AGE-induced BDNF release is a biological defense system in the early phase of diabetes. Chronic elevation of AGEs may induce depletion or downregulation of BDNF in platelets during the progression of DM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0505-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5299653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52996532017-02-13 Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation Furukawa, Kazuo Fuse, Ichiro Iwakura, Yuriko Sotoyama, Hidekazu Hanyu, Osamu Nawa, Hiroyuki Sone, Hirohito Takei, Nobuyuki Cardiovasc Diabetol Original Investigation BACKGROUND: Brain-derived neurotrophic factor (BDNF) exerts beneficial effects not only on diabetic neuropathies but also on cardiovascular injury. There is argument regarding the levels of serum BDNF in patients with diabetes mellitus (DM). Because BDNF in peripheral blood is rich in platelets, this may represent dysregulation of BDNF release from platelets. Here we focused on advanced glycation end products (AGEs), which are elevated in patients with DM and have adverse effects on cardiovascular functions. The aim of this study is to elucidate the role of AGEs in the regulation of BDNF release from human platelets. METHODS: Platelets collected from peripheral blood of healthy volunteers were incubated with various concentrations of AGE (glycated-BSA) at 37 °C for 5 min with or without BAPTA-AM, a cell permeable Ca(2+) chelator, or PP2, a potent inhibitor of Src family kinases (SFKs). Released and cellular BDNF were measured by ELISA and calculated. Phosphorylation of Src and Syk, a downstream kinase of SFKs, in stimulated platelets was examined by Western blotting and immunoprecipitation. RESULTS: AGE induced BDNF release from human platelets in a dose-dependent manner, which was dependent on intracellular Ca(2+) and SFKs. We found that AGE induced phosphorylation of Src and Syk. CONCLUSIONS: AGE induces BDNF release from human platelets through the activation of the Src-Syk-(possibly phospholipase C)-Ca(2+) pathway. Considering the toxic action of AGEs and the protective roles of BDNF, it can be hypothesized that AGE-induced BDNF release is a biological defense system in the early phase of diabetes. Chronic elevation of AGEs may induce depletion or downregulation of BDNF in platelets during the progression of DM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-017-0505-y) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-08 /pmc/articles/PMC5299653/ /pubmed/28178976 http://dx.doi.org/10.1186/s12933-017-0505-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Furukawa, Kazuo Fuse, Ichiro Iwakura, Yuriko Sotoyama, Hidekazu Hanyu, Osamu Nawa, Hiroyuki Sone, Hirohito Takei, Nobuyuki Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation |
title | Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation |
title_full | Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation |
title_fullStr | Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation |
title_full_unstemmed | Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation |
title_short | Advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the Src-family kinase activation |
title_sort | advanced glycation end products induce brain-derived neurotrophic factor release from human platelets through the src-family kinase activation |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299653/ https://www.ncbi.nlm.nih.gov/pubmed/28178976 http://dx.doi.org/10.1186/s12933-017-0505-y |
work_keys_str_mv | AT furukawakazuo advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation AT fuseichiro advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation AT iwakurayuriko advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation AT sotoyamahidekazu advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation AT hanyuosamu advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation AT nawahiroyuki advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation AT sonehirohito advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation AT takeinobuyuki advancedglycationendproductsinducebrainderivedneurotrophicfactorreleasefromhumanplateletsthroughthesrcfamilykinaseactivation |